| Late Stage Preclinical Projects | University of California, Los Angeles | Clinical Translation of Autologous Regenerative Pluripotent Stem Cell Therapy for Blindness |
$6,000,000 |
| Early Translational IV | University of California, Los Angeles | Stem Cell Programming With Chimeric Antigen Receptors to Eradicate HIV Infection |
$4,925,166 |
| New Cell Lines | University of California, Los Angeles | Generation of clinical grade human iPS cells |
$1,341,000 |
| Comprehensive Grant | University of California, Los Angeles | Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease |
$2,401,903 |
